10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000064803-22-000016`
Period End Date	20220331
Filing Date	20220504
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	cvs-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 99 Income Statement 40 Cash Flow Statement 76 Stockholders Equity 32 Comprehensive Income 16

Balance Sheet 99 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.41B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.44B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.60B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.90B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.12B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$24.43B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$26.45B	USD	Point-in-time
Inventories	`InventoryNet`	$18.16B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.76B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.29B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.53B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.74B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$60.01B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.75B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$61.48B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.32B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$22.59B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$23.02B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.90B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	422.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	441.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.84B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$18.80B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$19.12B	USD	Point-in-time
Goodwill	`Goodwill`	$79.06B	USD	Point-in-time
Goodwill	`Goodwill`	$79.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.03B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$28.54B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.67B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$5.09B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.71B	USD	Point-in-time
Total assets	`Assets`	$233.00B	USD	Point-in-time
Total assets	`Assets`	$232.87B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$12.74B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$12.54B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$18.57B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$17.33B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$8.81B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$10.26B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.30B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.14B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.62B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$17.67B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.39B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.30B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.65B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.85B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.21B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$4.22B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.78B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.81B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$17.79B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.18B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$52.06B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$51.97B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.27B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$5.83B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.67B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.36B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.40B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.90B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.24B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$157.62B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,747 shares issued and 1,306 shares outstanding at March 31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$47.38B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,747 shares issued and 1,306 shares outstanding at March 31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$47.68B	USD	Point-in-time
Treasury stock, at cost: 441 shares at March 31, 2022 and 422 shares at December 31, 2021	`TreasuryStockValue`	$30.14B	USD	Point-in-time
Treasury stock, at cost: 441 shares at March 31, 2022 and 422 shares at December 31, 2021	`TreasuryStockValue`	$28.17B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$54.91B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.49B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-190.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$965.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$75.08B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$73.83B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$310.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$233.00B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$232.87B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$21.63B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$18.96B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$168.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$297.00M	USD	1 Quarter
Total revenues	`Revenues`	$76.83B	USD	1 Quarter
Total revenues	`Revenues`	$69.10B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$45.51B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.89B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$15.70B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.95B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.92B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$9.88B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$73.34B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$65.52B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.58B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.49B	USD	1 Quarter
Interest expense	`InterestExpense`	$586.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$657.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$42.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$50.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.97B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.95B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$633.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$746.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income	`ProfitLoss`	$2.31B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.31B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.22B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.76	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.69	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.74	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.68	USD	1 Quarter
Weighted average basic shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average basic shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	1 Quarter
Weighted average diluted shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.55	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$66.49B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$74.19B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$39.17B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$44.37B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$15.46B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$16.62B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.97B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.27B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$199.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$222.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$782.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$876.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$44.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$96.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.89B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.18B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.57B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.47B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.13B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.05B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$829.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$84.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$31.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.99B	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.87B	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$252.00M	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.05B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$14.00M	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$656.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$722.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$212.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$297.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$62.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$59.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-149.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.19B	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.65B	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.16B	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.08B	USD	1 Quarter
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.61B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.04B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.88B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.61B	USD	Point-in-time
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income	`ProfitLoss`	$2.31B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.13B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.05B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$87.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$89.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-166.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-187.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.09B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.97B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$400.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-879.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$286.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$352.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$576.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.97B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$1.48B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$294.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$251.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-440.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.56B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.89B	USD	1 Quarter

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income	`ProfitLoss`	$2.31B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.16B	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$214.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$300.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.97B	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$76.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$730.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$660.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.14B	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income	`ProfitLoss`	$2.31B	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-386.00M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-1.16B	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.16B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.16B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.83B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.16B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.